Skip to content 
The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified. more
| Time Frame | KURE | S&P500 |
|---|---|---|
| 1-Week Return | -2.31% | -0.56% |
| 1-Month Return | 9.19% | 0.56% |
| 3-Month Return | 19.05% | 0.29% |
| 6-Month Return | 7.58% | 10.93% |
| 1-Year Return | -12.5% | 18.95% |
| 3-Year Return | 6.84% | 69.6% |
| 5-Year Return | -47.73% | 68.04% |
| 10-Year Return | -24.53% | 249.49% |
| Stock name | Ticker | Weight |
|---|---|---|
 INNOVENT BIOLOGICS INC | 1801.HK | 9.5% |
 BEONE MEDICINES LTD-H | 6160.HK | 8.84% |
 WUXI BIOLOGICS CAYMAN INC | 2269.HK | 7.35% |
 WUXI APPTEC CO LTD-A | 603259.SS | 5.6% |
 SHENZHEN MINDRAY BIO-MEDIC-A | 300760.SZ | 4.68% |
 JIANGSU HENGRUI PHARMACEUT-A | 600276.SS | 4.55% |
 AKESO INC | 9926.HK | 4.05% |
 SINO BIOPHARMACEUTICAL | 1177.HK | 3.69% |
 CSPC PHARMACEUTICAL GROUP LT | 1093.HK | 3.63% |
 WUXI APPTEC CO LTD-H | 2359.HK | 3.1% |
 HANSOH PHARMACEUTICAL GROUP | 3692.HK | 3.08% |
 GENSCRIPT BIOTECH CORP | 1548.HK | 2.86% |
 YUNNAN BAIYAO GROUP CO LTD-A | 000538.SZ | 2.2% |
 SICHUAN KELUN-BIOTECH BIOP-H | 6990.HK | 2.15% |
 3SBIO INC | 1530.HK | 2.15% |
 SHANGHAI UNITED IMAGING HE-A | 688271.SS | 2.11% |
 AIER EYE HOSPITAL GROUP CO-A | 300015.SZ | 1.87% |
 ZHANGZHOU PIENTZEHUANG PHA-A | 600436.SS | 1.81% |
 SICHUAN BIOKIN PHARMACEUTI-A | SICHUAN.BIOKIN.PHARMACEUTI.A | 1.76% |
 SICHUAN KELUN PHARMACEUTIC-A | 002422.SZ | 1.58% |
 PHARMARON BEIJING CO LTD-A | 300759.SZ | 1.57% |
 HAISCO PHARMACEUTICAL GROU-A | 002653.SZ | 1.47% |
 SINOPHARM GROUP CO-H | 1099.HK | 1.46% |
 XTALPI HOLDINGS LTD | 2228.HK | 1.46% |
 ASYMCHEM LABORATORIES TIAN-A | 002821.SZ | 1.32% |
 SHANGHAI ALLIST PHARMACEUT-A | 688578.SS | 1.23% |
 HUADONG MEDICINE CO LTD-A | 000963.SZ | 1.17% |
 SHANGHAI FOSUN PHARMACEUTI-A | 600196.SS | 1.16% |
 WUXI XDC CAYMAN INC | 2268.HK | 1.14% |
 SHANGHAI PHARMACEUTICALS-A | 601607.SS | 1.11% |
 REMEGEN CO LTD-A | 688331.SS | 1.06% |
 REMEGEN CO LTD-H | 9995.HK | 1.06% |
 CHINA RESOURCES SANJIU MED-A | 000999.SZ | 1% |
 SHENZHEN NEW INDUSTRIES BI-A | 300832.SZ | 0.96% |
 CSPC INNOVATION PHARMACEUT-A | 300765.SZ | 0.88% |
 SHENZHEN SALUBRIS PHARM-A | 002294.SZ | 0.87% |
 LEGEND BIOTECH CORP-ADR | LEGN | 0.86% |
 APT MEDICAL INC-A | 688617.SS | 0.85% |
 BEIJING TONG REN TANG CO-A | 600085.SS | 0.8% |
 CHINESE YUAN RENMINBI | CHINESE.YUAN.RENMINBI | 0.8% |
 SHANGHAI RAAS BLOOD PRODUC-A | 002252.SZ | 0.79% |
 IMEIK TECHNOLOGY DEVELOPME-A | 300896.SZ | 0.69% |
 HANGZHOU TIGERMED CONSULTI-A | 300347.SZ | 0.48% |
 HONG KONG DOLLAR | HONG.KONG.DOLLAR | 0% |
 KANGMEI PHARMA - RIGHTS O | KANGMEI.PHARMA...RIGHTS.O | 0% |
 Cash | Cash | -0.75% |
| Sector | Weight |
|---|---|
|
Health care | 99.06% |
|
Consumer staples | 0.94% |
KraneShares MSCI All China Health Care Index ETF (KURE) share price today is $18.655.
Yes, Indians can buy shares of KraneShares MSCI All China Health Care Index ETF (KURE) on Vested. To buy KURE from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of KraneShares MSCI All China Health Care Index ETF (KURE) on Vested. You can start investing in KraneShares MSCI All China Health Care Index ETF (KURE) with a minimum investment of $1.
The 52-week high price of KraneShares MSCI All China Health Care Index ETF (KURE) is $21.04. The 52-week low price of KraneShares MSCI All China Health Care Index ETF (KURE) is $14.38.
The stock symbol (or ticker) of KraneShares MSCI All China Health Care Index ETF is KURE.
Yes, you can setup SIP in KraneShares MSCI All China Health Care Index ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of KURE on the Vested app.
The expense ratio of KraneShares MSCI All China Health Care Index ETF (KURE) is 0.65%.
Link copied 
